No DOCE (n=56) | DOCE (n=33) | P value* | |
Age (years) | 64.5±9.8 | 67.1±9.9 | ns |
Males (%) | 51 (91) | 27 (82) | ns |
Presentation (%) | |||
Chronic coronary syndrome | 37 (66) | 21 (64) | ns |
Acute coronary syndrome | 19 (34) | 12 (36) | ns |
Cardiovascular risk factors (%) | |||
Arterial hypertension (%) | 40 (71) | 27 (82) | ns |
Diabetes mellitus (%) | 9 (16) | 15 (45) | 0.02 |
Dyslipidaemia (%) | 41 (73) | 29 (88) | ns |
Current smoking (%) | 29 (52) | 20 (61) | ns |
Previous MI (%) | 29 (52) | 13 (40) | ns |
Previous CABG (%) | 5 (9) | 7 (12) | ns |
Antithrombotics (%) | |||
Aspirin | 55 (98) | 33 (100) | ns |
Clopidogrel | 36 (64) | 23 (70) | ns |
Ticagrelor | 8 (14) | 6 (18) | ns |
Prasugrel | 7 (12) | 8 (24) | ns |
Oral anticoagulant | 3 (3.4) | 0 (0.0) | – |
Access (%) | |||
Radial | 45 (80) | 29 (88) | ns |
Femoral | 11 (20) | 4 (12) | ns |
Culprit vessel (%) | |||
Left anterior descending | 14 (25) | 10 (30) | ns |
Left circumflex | 15 (27) | 5 (15) | ns |
Right coronary artery | 26 (46) | 19 (58) | ns |
Type of in-stent restenosis (%) | |||
(1)Focal | 17 (30) | 7 (21) | ns |
(2) Diffuse | 20 (36) | 11 (33) | ns |
(3) Proliferative | 12 (21) | 7 (21) | ns |
(4) Occlusive | 3 (7) | 8 (24) | 0.02 |
Data are mean (SD) or number (percentage), as appropriate.
*P values were based on Student’s t-tests, Mann-Whitney U tests, as appropriate.
CABG, coronary artery bypass; DOCE, device-oriented composite endpoint; MI, myocardial infarction; ns, not significant.